Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sunflower Therapeutics has launched its Daisy Petal™ perfusion bioreactor system and Dahlia Petal™ fermentation system. These platforms enable continuous protein manufacturing with yields five to ten times higher than traditional methods. The systems have been installed at educational labs and are being commercialized globally through partnerships. The company's approach has received industry recognition ("Lifescience Manufacturing Solution of the Year") and significant investment from strategic partners such as SK bioscience.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sunflower Life Sciences.